The influence of sex hormones on musculoskeletal pain and osteoarthritis

[1]  M. Gulati,et al.  Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study , 2022, The Lancet. Rheumatology.

[2]  E. Dennison.  Osteoarthritis: The importance of hormonal status in midlife women. , 2022, Maturitas.

[3]  G. Kenter,et al.  Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy , 2022, Journal of the Endocrine Society.

[4]  Qiang Liu,et al.  Prevalence Trends of Site‐Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019 , 2022, Arthritis & rheumatology.

[5]  Vijay Kumar Chattu,et al.  Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.

[6]  T. Pizzari,et al.  Does Menopausal Hormone Therapy, Exercise, or Both Improve Pain and Function in Postmenopausal Women With Greater Trochanteric Pain Syndrome? A 2 × 2 Factorial Randomized Clinical Trial , 2021, The American journal of sports medicine.

[7]  Tom R. Gaunt,et al.  Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations , 2021, Cell.

[8]  D. Shin,et al.  Female reproductive factors and risk of joint replacement arthroplasty of the knee and hip due to osteoarthritis in postmenopausal women: A nationwide cohort study of 1.13 million women. , 2021, Osteoarthritis and cartilage.

[9]  A. Brufsky,et al.  Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management , 2021, Frontiers in Endocrinology.

[10]  F. Ross,et al.  Low bone mass resulting from impaired estrogen signaling in bone increases severity of load-induced osteoarthritis in female mice. , 2021, Bone.

[11]  B. Mahata,et al.  Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies , 2021, Genes & Immunity.

[12]  B. Cairns,et al.  Peritraumatic 17β-estradiol levels influence chronic posttraumatic pain outcomes. , 2021, Pain.

[13]  U. Turpeinen,et al.  Adipose tissue estrogen production and metabolism in premenopausal women , 2021, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  J. Ablin,et al.  Pain and transition: evaluating fibromyalgia in transgender individuals. , 2021, Clinical and experimental rheumatology.

[15]  Helen Waller-Evans,et al.  Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease , 2020, Essays in biochemistry.

[16]  A. Fioravanti,et al.  Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects , 2020, International journal of molecular sciences.

[17]  K. Izumi,et al.  Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study) , 2020, Andrologia.

[18]  K. Sluka,et al.  Testosterone protects against the development of widespread muscle pain in mice. , 2020, Pain.

[19]  F. Dell’Accio,et al.  Does Pain at an Earlier Stage of Chondropathy Protect Female Mice Against Structural Progression After Surgically Induced Osteoarthritis? , 2020, Arthritis & rheumatology.

[20]  Shidou Zhao,et al.  FANCL gene mutations in premature ovarian insufficiency , 2020, Human mutation.

[21]  S. Jick,et al.  Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis. , 2020, Maturitas.

[22]  C. Coupland,et al.  Comorbidities in Osteoarthritis: A Systematic Review and Meta‐Analysis of Observational Studies , 2020, Arthritis care & research.

[23]  G. Giles,et al.  Female Reproductive and Hormonal Factors and Incidence of Primary Total Knee Arthroplasty Due to Osteoarthritis , 2018, Arthritis & rheumatology.

[24]  F. Watt.  Musculoskeletal pain and menopause , 2018, Post reproductive health.

[25]  P. Kantoff,et al.  Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer. , 2017, Journal of pain and symptom management.

[26]  M. Bovenzi,et al.  Serum dehydroepiandrosterone sulphate, psychosocial factors and musculoskeletal pain in workers. , 2017, Occupational medicine.

[27]  Y. X. Wáng,et al.  Menopause as a potential cause for higher prevalence of low back pain in women than in age-matched men , 2016, Journal of orthopaedic translation.

[28]  K. Chin,et al.  A concise review of testosterone and bone health , 2016, Clinical interventions in aging.

[29]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[30]  G. Giles,et al.  Relationship between circulating sex steroid hormone concentrations and incidence of total knee and hip arthroplasty due to osteoarthritis in men. , 2016, Osteoarthritis and cartilage.

[31]  B. Billah,et al.  Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey , 2016, Menopause.

[32]  A. Hofman,et al.  Lower sex hormone levels are associated with more chronic musculoskeletal pain in community-dwelling elderly women , 2016, Pain.

[33]  D. Flockhart,et al.  Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons , 2016, Experimental Neurology.

[34]  F. Tian,et al.  Are estrogen-related drugs new alternatives for the management of osteoarthritis? , 2016, Arthritis Research & Therapy.

[35]  F. Watt.  Hand osteoarthritis, menopause and menopausal hormone therapy. , 2016, Maturitas.

[36]  N. Pendleton,et al.  Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS. , 2015, The Journal of clinical endocrinology and metabolism.

[37]  Christian Gieger,et al.  An omics investigation into chronic widespread musculoskeletal pain reveals epiandrosterone sulfate as a potential biomarker , 2015, Pain.

[38]  T. Travison,et al.  Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial , 2015, Pain.

[39]  G. Macfarlane,et al.  The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria , 2015, Arthritis & rheumatology.

[40]  G. Giles,et al.  Incidence of Total Knee and Hip Replacement for Osteoarthritis in Relation to Circulating Sex Steroid Hormone Concentrations in Women , 2014, Arthritis & rheumatology.

[41]  C. Atabekoğlu,et al.  Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[42]  F. Paulsen,et al.  Articular cartilage chondrocytes express aromatase and use enzymes involved in estrogen metabolism , 2014, Arthritis Research & Therapy.

[43]  G. Herrero-Beaumont,et al.  Selective estrogen receptor modulators (SERMs): new alternatives for osteoarthritis? , 2014, Maturitas.

[44]  Daniel Prieto-Alhambra,et al.  Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints , 2013, Annals of the rheumatic diseases.

[45]  L. Carbone,et al.  Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial , 2013, Menopause.

[46]  P. Niravath.  Aromatase inhibitor-induced arthralgia: a review. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  J. Blümel,et al.  Menopause could be involved in the pathogenesis of muscle and joint aches in mid-aged women. , 2013, Maturitas.

[48]  I. Tracey,et al.  Brain imaging reveals that engagement of descending inhibitory pain pathways in healthy women in a low endogenous estradiol state varies with testosterone , 2013, PAIN.

[49]  P. Sluss,et al.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging , 2012, Menopause.

[50]  Lang Li,et al.  Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  M. Sousa,et al.  Influence of cortisol and DHEA-S on pain and other symptoms in post menopausal women with fibromyalgia. , 2012, Journal of back and musculoskeletal rehabilitation.

[52]  A. Silman,et al.  Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men , 2011, PAIN®.

[53]  J. Eng-Wong,et al.  The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms , 2011, Breast Cancer Research and Treatment.

[54]  A. Hofman,et al.  Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysis , 2010, BMC Medical Genetics.

[55]  I. Tracey,et al.  Sex Hormones and Pain: The Evidence From Functional Imaging , 2010, Current pain and headache reports.

[56]  A. Silman,et al.  Identification of late-onset hypogonadism in middle-aged and elderly men. , 2010, The New England journal of medicine.

[57]  G. Moxley.  Rheumatic disorders and functional disability with aromatase inhibitor therapy. , 2010, Clinical breast cancer.

[58]  T. Fujita,et al.  Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis , 2010, Journal of Bone and Mineral Metabolism.

[59]  G. Herrero-Beaumont,et al.  Osteoarthritis associated with estrogen deficiency , 2009, Arthritis research & therapy.

[60]  F. OlaOlorun,et al.  Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria , 2009, Menopause.

[61]  J. V. van Meurs,et al.  Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip: a systematic review. , 2009, Rheumatology.

[62]  V. Beral,et al.  Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women , 2008, Annals of the rheumatic diseases.

[63]  I. Tracey,et al.  Hormones and Their Interaction with the Pain Experience , 2008, Reviews in pain.

[64]  Stephen Safe,et al.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. , 2008, Journal of molecular endocrinology.

[65]  J. Cuzick,et al.  Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. , 2008, The Lancet. Oncology.

[66]  T. Meade,et al.  Health related quality of life after combined hormone replacement therapy: randomised controlled trial , 2008, BMJ : British Medical Journal.

[67]  H Weinans,et al.  Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment - a systematic approach. , 2008, Osteoarthritis and cartilage.

[68]  L. Dennerstein,et al.  The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study , 2008, Climacteric : the journal of the International Menopause Society.

[69]  A. Aloisi,et al.  Cross-sex hormone administration changes pain in transsexual women and men , 2007, PAIN.

[70]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[71]  S. Glasson,et al.  Osteoarthritis severity is sex dependent in a surgical mouse model. , 2007, Osteoarthritis and cartilage.

[72]  M. Angst,et al.  Experimental Heat Pain for Detecting Pregnancy-Induced Analgesia in Humans , 2006, Anesthesia and analgesia.

[73]  L. Dennerstein,et al.  Factors affecting the prevalence of osteoarthritis in healthy middle-aged women: data from the longitudinal Melbourne Women's Midlife Health Project. , 2006, Bone.

[74]  T. Nickelsen,et al.  Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration , 2006, Current medical research and opinion.

[75]  R. Wallace,et al.  Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative. , 2006, Arthritis and rheumatism.

[76]  Claus Christiansen,et al.  Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. , 2006, Arthritis and rheumatism.

[77]  Marco Bonifazi,et al.  Sex hormones, central nervous system and pain , 2006, Hormones and Behavior.

[78]  G. Barr,et al.  Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats , 2006, Hormones and Behavior.

[79]  M. Brincat,et al.  Intervertebral disc height in treated and untreated overweight post-menopausal women. , 2005, Human reproduction.

[80]  L. Leresche,et al.  Relationship of pain and symptoms to pubertal development in adolescents , 2005, Pain.

[81]  J. Manson,et al.  Symptom Experience After Discontinuing Use of Estrogen Plus Progestin , 2005 .

[82]  Susan R. Johnson,et al.  Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Women's Health Initiative , 2005, Obstetrics and gynecology.

[83]  R. Henderson,et al.  Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. , 2005, Immunology letters.

[84]  A. Aloisi,et al.  Gonadectomy Affects Hormonal and Behavioral Responses to Repetitive Nociceptive Stimulation in Male Rats , 2003, Annals of the New York Academy of Sciences.

[85]  F. Parazzini.  Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. , 2003, Maturitas.

[86]  P. Richette,et al.  Estrogens, cartilage, and osteoarthritis. , 2003, Joint, bone, spine : revue du rhumatisme.

[87]  F. Cicuttini,et al.  Factors affecting knee cartilage volume in healthy men. , 2003, Rheumatology.

[88]  F. Cicuttini,et al.  Users of oestrogen replacement therapy have more knee cartilage than non-users , 2001, Annals of the rheumatic diseases.

[89]  T. Spector,et al.  Menopause, oestrogens and arthritis. , 2000, Maturitas.

[90]  C. Cooper,et al.  Hormone replacement therapy, other reproductive variables and symptomatic hip osteoarthritis in elderly white women: a case-control study. , 1998, British journal of rheumatology.

[91]  T. Spector,et al.  Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford study , 1997, Annals of the rheumatic diseases.

[92]  M. Soliman,et al.  The Effects of Estradiol and Progesterone on Pain Sensitivity and Brain Opioid Receptors in Ovariectomized Rats , 1996, Hormones and Behavior.

[93]  A. Gintzler,et al.  Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms , 1996, Pain.

[94]  M. Sowers,et al.  Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. , 1996, American journal of epidemiology.

[95]  A. Silman,et al.  Frequency of osteoarthritis in hysterectomized women. , 1991, The Journal of rheumatology.

[96]  R. Moskowitz,et al.  Estradiol receptors in articular chondrocytes. , 1982, Biochemical and biophysical research communications.

[97]  R. Swann.  Chronic pelvic pain in women. , 1957, Journal. Iowa State Medical Society.